Other reported cases
3,490 cases
14 days × average intensity 5
3,490 × 14 × 24 × 5 ÷ 47.25
≈ 35.6 USU per caseEstimated total for this group: about 124 thousand USU.
Disease outbreak
Experimental estimate · v0.11Report prepared 8 October 2026
Acute illness, including fatal cases
Confirmed-case population. Source context
confirmed cases
1 USU is the modeled burden of one specified six-hour kidney-stone pain reference. It is a common reporting unit, not a claim that the experiences feel the same.
Approximate, assumption-based USU for the included experience. Deaths are a separate measure. Includes fatal illness.
Reading the result
About 244 thousand USU is assigned to the 6,757 confirmed cases in this snapshot. The estimate combines ordinary illness allowances for 3,490 other reported cases with complete fatal illness courses for 3,267 reported deaths. This models suffering before death. It does not assign a value to death itself or to lost life years.
Population count × modeled average ≈ total USU
This is a modeled average across the included cases. Other reported cases are assigned about 35.6 USU each; reported fatal cases are assigned about 36.6 USU each. Each course is weighted by its case count. The average can differ between outbreaks because the reported mix of cases differs, even when the same course assumptions are used. See the two courses and their assumed durations →
This is an assumption-based average, not an observed average or a prediction for any individual. Figures shown here are rounded; calculations use unrounded values. How to read these averages.
This template draws on small studies of earlier Bundibugyo-virus outbreaks. It does not use patient-level duration or pain measurements from the 2026 outbreak. Persistent symptoms after the acute illness are unestimated.
The calculation
6,757 confirmed cases = 3,490 other reported cases + 3,267 reported fatal cases. “Other” includes unresolved outcomes and does not mean known survivors or mild cases.
3,490 cases
14 days × average intensity 5
3,490 × 14 × 24 × 5 ÷ 47.25
≈ 35.6 USU per caseEstimated total for this group: about 124 thousand USU.
3,267 cases
12 days × average intensity 6
3,267 × 12 × 24 × 6 ÷ 47.25
≈ 36.6 USU per caseEstimated total for this group: about 119 thousand USU.
Rounded for readability. The downloadable inputs retain the calculation precision.
The fatal course replaces the ordinary allowance for those same cases. It covers the complete illness ending at death, so there is no additional terminal-period charge. Death itself, lost life years and bereavement are not assigned USU.
Intensity is a combined 0–10 average over the elapsed course, including relief, sleep and intervals without experience. No intensity is assigned after death or to known absence of experience. Why divide by 47.25?
The original all-case assumption of 14 days is retained for cases not reported dead at the cutoff. Historical series reported courses around 9-10 days in Uganda and 15-18 days in Isiro. Fourteen days is a rounded choice, not a pooled mean, a survivor-specific estimate or an observed 2026 average. Unresolved cases remain in this group; no future deaths are imputed. [S14] [S15]
The studies describe headache, muscle and abdominal pain, gastrointestinal symptoms and marked weakness. We assign intensity 5 as a provisional combined whole-day average, allowing for treatment, relief and sleep. Neither study measured USU intensity. Choosing 5 rather than the dengue value 3 or chikungunya value 4 is a model judgment, not a demonstrated clinical ratio. [S14] [S15]
We select 12 days between the historical median onset-to-death durations of 9 days in Uganda and 15 days in Isiro. It represents the complete symptomatic course ending at death, not an extra terminal period. It is not a pooled mean or an observed 2026 average; the studies were small and treatment settings differed. [S14] [S15]
We assign intensity 6 as a combined time-average of pain and other acute distress over the whole fatal course, including relief, sleep and intervals without experience. This is a provisional judgment above the existing value 5, not a measured USU mapping. Concurrent symptoms are represented together and are not added again. No intensity is assigned after death or to known absence of experience. [S14] [S15]
Version 0.3 assigned the same 14-day, intensity-5 course to all 6,757 cases: 240,248.89 USU. The revised estimate is 243,567.75 USU, a change of +3,318.86 USU (+1.381%).
For the 3,267 reported fatal cases, 116,160.00 USU is removed and replaced with 119,478.86 USU. The reference unit and source counts are unchanged.
Testing the assumptions
Under the central assumptions, other reported cases contribute 50.9%; reported fatal cases contribute 49.1% of the total. Both courses are varied below.
Each row uses the same reported counts and included experiences. The lower and higher rows change duration and intensity together for every included course.
| Scenario | Assumed courses | Estimated USU |
|---|---|---|
| Lower assumptions | Other reported cases: 7 days at intensity 3 Reported fatal cases: 9 days at intensity 5 | 112 thousand |
| Central assumptions | Other reported cases: 14 days at intensity 5 Reported fatal cases: 12 days at intensity 6 | 244 thousand |
| Higher assumptions | Other reported cases: 21 days at intensity 7 Reported fatal cases: 15 days at intensity 7 | 435 thousand |
These are alternative assumptions, not confidence intervals or bounds. Counts can be incomplete or misclassified; omitted experiences and the validity of the intensity scale remain outside this calculation. Actual burden could fall outside these examples.
Only the named input changes. Every other duration, intensity and count stays at its central value. Each result is the total for the whole report.
| Input varied | Lower input and resulting total | Higher input and resulting total |
|---|---|---|
| Other reported cases Duration | 7 days 182 thousand USU | 21 days 306 thousand USU |
| Other reported cases Average intensity | 3 / 10 194 thousand USU | 7 / 10 293 thousand USU |
| Reported fatal cases Duration | 9 days 214 thousand USU | 15 days 273 thousand USU |
| Reported fatal cases Average intensity | 5 / 10 224 thousand USU | 7 / 10 263 thousand USU |
Fatal illness remains a replacement course for the same reported fatal cases; no case is counted twice. How the scenarios are chosen.
Download scenario calculations (CSV) · Reproduce the scenarios (Python)
Coverage
One complete acute illness course per confirmed case, combining pain, gastrointestinal symptoms and other acute distress. The 3,267 cases reported dead receive a 12-day, intensity-6 fatal course; the other 3,490 cases retain the 14-day, intensity-5 assumption. These are disjoint groups, not extra cases. Other reported cases include unresolved outcomes and are not all known survivors.
WHO reported 6,757 confirmed cases in DR Congo through 7 September 2026, including two cases diagnosed there and subsequently treated in Germany. We retain WHO’s country attribution. Cases reported in Uganda and France, contacts under monitoring, and suspected or unreported cases are excluded. This is a cumulative outbreak snapshot, not the number currently ill. Some outcomes were still unresolved at the cutoff. [S13]
Incubation without symptoms, persistent post-Ebola symptoms, caregiver distress, bereavement, unconfirmed or unreported illness, and post-death loss. Individual severity and time to death or recovery are not reconstructed.
Omitted experiences are unestimated, not known to be zero. This is not a complete event total or a guaranteed lower bound.
Whole representative courses are assigned to the source-defined cases or cohort. Course time can extend beyond the reporting dates. The fatal course ends at death; individual symptom histories and timing are not reconstructed. Other cases include unresolved outcomes, and no future deaths are imputed. No causal baseline or suffering after death is assigned.
Deaths remain separate
WHO reported 3,267 deaths among the 6,757 confirmed cases attributed to DR Congo through 7 September 2026. These deaths identify the cases assigned a fatal illness course. They are removed from the ordinary group and are not added as extra cases. The mortality count remains visible as a separate measure. [S13]
A complete fatal illness course is included for 3,267 source-defined fatal cases. It replaces their ordinary allowance; each case receives one course. This does not cover every possible death or consequence.
Why this death count fits the calculation: WHO identifies the 3,267 deaths within the same 6,757 confirmed cases attributed to DR Congo through 7 September 2026. [S13]
USU estimates experienced suffering during lived time. Death itself and lost life years are not assigned USU. A report can use a death count to identify a distinct course of suffering before death, as in the disease fatal-course calculations. Bereavement remains unestimated.
Trace the estimate
Stipulated six-hour kidney-stone reference: 47.25 modeled intensity-hours, with linear weighting. This convention defines the unit; it is not a measured equivalence between conditions.
6,757 confirmed cases and 3,267 deaths in DR Congo through 7 September 2026. Country count includes two cases diagnosed there and subsequently treated in Germany; excludes Uganda and France.
Small historical clinical series: median onset-to-death duration 9 days in 11 fatal cases, range 3-20. Informs a representative fatal course; it does not establish a 2026 mean or USU intensity.
Small historical clinical series: median onset-to-death duration 15 days, range 4-28. Documentation and setting limitations restrict transfer to 2026; it does not calibrate USU intensity.